CD39+ virus-specific CD4+ T-cells increased during infection, peaked at day 88 after the onset of symptoms (63.2%) for the index patient and day 25 (41.38%) for the reference patient, and continuously decreased afterward. Here, ENTPD1 is linked to infection.